Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rallybio Corporation - Common Stock (NQ: RLYB )

0.6478 -0.0082 (-1.25%)
Streaming Delayed Price Updated: 1:07 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rallybio Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Rallybio Announces Acceptance of Abstract for RLYB212 at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH)
From Rallybio Corporation
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another dive into the biggest pre-market stock movers for Thursday with all the companies traders need to watch! 
Via InvestorPlace
Rallybio Pulls Plug On One Candidate After Highlighting Encouraging Data From Another Thrombocytopenia Program
Via Benzinga
Rallybio Reports Fourth Quarter and Full Year 2022 Financial Results
From Rallybio Corporation
Via Business Wire
Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
From Rallybio Corporation
Via Business Wire
EyePoint Pharma Posts Deeper Losses For Q4, Expects Cash Runway Into 2024
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported Q4 revenues of $10.5 million, down 8.8% Y/Y, almost in line with the consensus of $10.40 million. 
Via Benzinga
Rallybio to Present at Upcoming Investor Conferences in March
From Rallybio Corporation
Via Business Wire
EyePoint and Rallybio Announce Research Collaboration to Evaluate Rallybio’s Inhibitor of Complement Component 5 (C5) and EyePoint’s Proprietary Durasert® Technology for Sustained Intraocular Delivery in Geographic Atrophy
From Rallybio Corporation
Via Business Wire
Rallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officer
From Rallybio Corporation
Via Business Wire
Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2023
From Rallybio Corporation
Via Business Wire
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
Via Benzinga
RCI Hospitality, AbCellera Biologics And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 600 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Rallybio Announces Publication of Data Highlighting the Ability of HPA-1a-Specific Antibodies to Prevent Alloimmunization in an Authentic Mouse Model of FNAIT
From Rallybio Corporation
Via Business Wire
Dow Jumps 600 Points; US Inflation Rate Slows In November
U.S. stocks traded higher this morning, with the Dow Jones gaining over 600 points on Tuesday 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday saw 196 companies set new 52-week lows. 
Via Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
From Rallybio Corporation
Via Business Wire
Rallybio to Present at the JMP Securities Hematology and Oncology Summit
From Rallybio Corporation
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. 
Via Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program. 
Via Benzinga
Rallybio to Present at Upcoming Investor Conferences in November
From Rallybio Corporation
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 63 stocks hit new 52-week lows. 
Via Benzinga
Rallybio Announces Pricing of $50 Million Public Offering
From Rallybio
Via Business Wire
Rallybio Announces Proposed Public Offering
From Rallybio Corporation
Via Business Wire
Rallybio Reports Third Quarter 2022 Financial Results
From Rallybio Corporation
Via Business Wire
Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
From Rallybio Corporation
Via Business Wire
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
   Losers 
Via Benzinga
Peering Into Rallybio's Recent Short Interest
Rallybio's (NASDAQ:RLYB) short percent of float has fallen 4.94% since its last report. The company recently reported that it has 638 thousand shares sold short, which is 2.5% of all regular shares... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.